MRSH
$176.48+5.57 (+3.26%)
Marsh & McLennan Companies, Inc., a professional services company, provides advisory services and insurance solutions to clients in the areas of risk, strategy, and people worldwide.
Recent News
Marsh & McLennan (MRSH) Stock Is Up, What You Need To Know
Shares of professional services firm Marsh & McLennan (NYSE:MRSH) jumped 2.9% in the afternoon session after its business, Mercer, agreed to acquire AltamarCAM, a specialist private markets asset manager and solutions provider.
Marsh & McLennan Stock: Is MRSH Underperforming the Financial Sector?
Marsh & McLennan has lagged behind the broader financial sector over the past year, but analysts remain reasonably bullish about the stock’s prospects.
Assessing Marsh & McLennan (MRSH) Valuation After Recent Share Price Weakness
Recent performance snapshot Marsh & McLennan Companies (MRSH) has seen mixed share performance recently, with a 0.7% move over the past day, a 6.0% decline over the past week, and negative returns over the month and past 3 months. See our latest analysis for Marsh & McLennan Companies. At a share price of $172.15, Marsh & McLennan Companies has seen short term share price pressure, with the 7 day share price return of a 6.0% decline contributing to a year to date share price return of a 5.66%...
Is Marsh & McLennan Companies, Inc. (MRSH) A Good Stock To Buy?
Is MRSH a good stock to buy? We came across a bullish thesis on Marsh & McLennan Companies, Inc. on Ocular Capital’s Substack. In this article, we will summarize the bulls’ thesis on MRSH. Marsh & McLennan Companies, Inc.’s share was trading at $173.97 as of March 11th. MRSH’s trailing and forward P/E were 20.64 and 16.75 respectively […]
Marsh & McLennan Companies, Inc. (MRSH) Target Lowered by Barclays as AI Selloff Seen Overdone
We recently compiled a list of the 10 Oversold Insurance Stocks to Buy According to Analysts. Marsh & McLennan Companies, Inc. (NYSE:MRSH) is among the most oversold stocks. TheFly reported on March 11 that Barclays adjusted its price target for MRSH to $209 from $210, while the firm maintained an Overweight rating on the stock. […]